bluewillow.comHealthcareFounded: 2000Funding to Date: $37.19MM
BlueWillow Biologics (also known as NanoBio) are the developer of intranasal vaccines that help protect global populations from food allergies, sexually transmitted diseases and respiratory infections. This company was founded in 2000 by James Baker and is headquartered in Ann Arbor, MI. BlueWillow's antiseptic and anti-infective products as well as NanoVax are using a patented nanotechnology platform to administrate nano-droplets to the skin and nose.
View Enterprise Value for BlueWillow Biologics.